Pilot study of levodopa dose as treatment for residual amblyopia in children aged 8 years to younger than 18 years
- PMID: 20837811
- PMCID: PMC3137458
- DOI: 10.1001/archophthalmol.2010.178
Pilot study of levodopa dose as treatment for residual amblyopia in children aged 8 years to younger than 18 years
References
-
- Leguire LE, Walson PD, Rogers GL, Bremer DL, McGregor ML. Longitudinal study of levodopa/carbidopa for childhood amblyopia. J Pediatr Ophthalmol Strabismus. 1993;30(6):354–60. - PubMed
-
- Leguire LE, Walson PD, Rogers GL, Bremer DL, McGregor ML. Levodopa/carbidopa treatment for amblyopia in older children. J Pediatr Ophthalmol Strabismus. 1995;32:143–51. - PubMed
-
- Leguire LE, Narius TM, Rogers GL, Bremer DL, McGregor ML. Long-term follow-up L-dopa treated amblyopic children. Invest Ophthalmol Vis Sci. 1996;37(supp 3):S941.
-
- Leguire LE, Komaromy KL, Nairus TM, Rogers GL. Long-term follow-up of L-dopa treatment in children with amblyopia. J Pediatr Ophthalmol Strabismus. 2002;39(6):326–30. - PubMed
-
- Gottlob ISWS, Reinecke RD. Visual acuities and scotomas after 3 weeks’ levodopa administration in adult amblyopia. Graefes Arch Clin Exp Ophthalmol. 1995;233(7):407–13. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
